Administration of antisense oligonucleotide against pro-opiomelanocortin prevents enduring hormonal alterations induced by neonatal handling in male mice

European Journal of Pharmacology

Volumn 550, Issue 1-3, 2006, Pages 180-185

  Galietta, Gabriella ^a,d   Loizzo, Alberto ^a   Loizzo, Stefano ^a   Trombetta, Giuseppe ^a,b   Spampinato, Santi ^c   Campana, Gabriele ^c   Capasso, Anna ^d   Palermo, Mario ^e   Guarino, Irene ^a,e   Franconi, Flavia ^e  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ASL 8 Calabria   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

Adrenocorticotropin; Corticosteroid; Corticotropin releasing hormone; Hypothalamus pituitary adrenal axis; Neonatal programming; Pro opiomelanocortin antisense

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; PROOPIOMELANOCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIRTH; BODY WEIGHT; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEANING;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANIMALS, NEWBORN; BETA-ENDORPHIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HANDLING (PSYCHOLOGY); HORMONES; MALE; MICE; OLIGONUCLEOTIDES, ANTISENSE; PRO-OPIOMELANOCORTIN; STRESS, PSYCHOLOGICAL;

EID: 33750006305     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.072     Document Type: Article

References (52)

1. Bandelow B., Krause J., Wedekind D., Broocks A., Hajak G., and Ruther E. Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls. Psych. Res. 134 (2005) 169-179
2. Banks W.A., Farr S.A., Butt W., Kumar V.B., Franko M.W., and Morley J.E. Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein. J. Pharmacol. Exp. Ther. 297 (2001) 1113-1121
3. Barker D.J., Osmond C., Rodin I., Fall C.H., and Winter P.D. Low weight gain in infancy and suicide in adult life. Br. Med. J. 311 (1995) 1203
4. Bradbury M.J., Strack A.M., and Dallman M.F. Lesions of the hippocampal efferent pathway (fimbria-fornix) do not alter sensitivity of adrenocortocotropin to feedback inhibition by corticosterone in rats. Neuroendocrinology 58 (1993) 396-407
5. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Burd L., Severud R., Kerbeshian J., and Klug M.G. Prenatal and perinatal risk factors for autism. J. Perinat. Med. 27 (1999) 441-450
7. Clark P.M. Programming of the hypothalamic-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Eur. J. Pediatr. 157 (1998) S7-S10
8. Clot-Faybesse O., Guieu R., Rochat H., and Devaux C. Toxicity during early development of the mouse nervous system of a scorpion neurotoxin active on sodium channels. Life Sci. 66 (2000) 185-192
9. d'Amore A., Mazzucchelli A., Renzi P., and Loizzo A. Effect of naloxone on the long term weight gain induced by repeated postnatal stress in male mice. Behav. Pharmacol. 7 (1996) 430-436
10. De Kloet E.R. Hormones, brain and stress. Endocr. Regul. 37 (2003) 51-68
11. Doyle L.W., Ford G.W., Davis N.M., and Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin. Sci. 98 (2000) 137-142
12. Edwards H.E., and McIntyre Burnham W. The impact of corticosteroids on the developing animal. Pediatr. Res. 50 (2001) 433-440
13. Feng P., Ma Y., and Vogel G.W. The critical window of brain development from susceptive to insusceptive. Effects of clomipramine neonatal treatment on sexual behavior. Brain Res. Dev. Brain Res. 129 (2001) 107-110
14. Fontana F., Bernardi P., Pich E.M., Boschi S., De Iasio R., Spampinato S., and Grossi G. Opioid peptide modulation of circulatory and endocrine response to mental stress in humans. Peptides 18 (1997) 169-175
15. Forte A., Cipollaro M., Cascino A., and Galderisi U. Small interfering RNAs and antisense oligonucleotides for treatment of neurological diseases. Curr. Drug Targets 6 (2005) 21-29
16. Franconi F., Diana G., Fortuna A., Galietta G., Seghieri G., Trombetta G., Valentini G., and Loizzo A. Taurine administration during lactation modifies hippocampal CA1 neurotransmission and behavioural programming in adult male mice. Brain Bull. Res. 63 (2004) 491-497
17. Garofolo M.C., Seidler F.J., Cousins M.M., Tate C.A., Qiao D., and Slotkin T.A. Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver. Brain Res. Bull. 59 (2003) 319-329
18. Godfray K.M., and Baker D.J.P. Fetal programming and adult health. Public Health Nutr. 4 (2001) 611-624
19. Heim C., and Nemeroff C.B. The role of childhood trauma in the neurobiology and mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 49 (2001) 1023-1039
20. Huttunen M.O., and Niskanen P. Prenatal loss of father and psychiatric disorders. Arch. Gen. Psychiatry 35 (1978) 429-431
21. Jansen B., and Zangemeister-Wittke U. Antisense therapy for cancer-the time of truth. Lancet Oncol. 3 (2002) 672-683
22. Jones J.P., Meck W.H., Williams C.L., Wilson W.A., and Swartzwelder H.S. Choline availability to the developing rat fetus alters adult hippocampal long-term potentiation. Brain Res. Dev. Brain Res. 118 (1999) 159-167
23. Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 270 (2003) 1628-1644
24. Ladd C.O., Huot R.L., Thrivikraman K.V., Nemeroff C.B., and Plotsky P.M. Long-term adaptations in glucocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following maternal separation. Biol. Psychiatry 55 (2004) 367-375
25. Levine S. Maternal and environmental influences on the adrenocortical response to stress in weanling rats. Science 156 (1957) 258-260
26. Levitt N.S., Lambert E.V., Woods D., Hales C.N., Andrew R., and Seckl J.R. Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young south African adults: early programming of cortisol axis. J. Clin. Endocrinol. Metab. 85 (2000) 4611-4618
27. Loizzo A., Loizzo S., Lopez L., d'Amore A., Renzi P., Spampinato S., Di Carlo S., Bacosi A., Zuccaro P., and Pacifici R. Naloxone prevents cell-mediated immuno alterations in adult mice following repeated mild stress in the neonatal period. Br. J. Pharmacol. 135 (2002) 1219-1226
28. Loizzo A., Capasso A., Galietta G., Severini C., Campana G., and Spampinato S. Vas deferens response to selective opioid receptors agonists in adult mice is impaired following postnatal repeated mild stress. Eur. J. Pharmacol. 458 (2003) 201-205
29. Loizzo A., Loizzo S., Galietta G., Caiola S., Spampinato S., Campana S., Seghieri S., Ghirlanda G., and Franconi F. Overweight and metabolic and hormonal parameters disruption, are induced in adult male mice by manipulations during lactation period. Pediatr. Res. 59 (2006) 111-116
30. Matthews S.G. Antenatal glucocorticoids and programming of the developing CNS. Pediatr. Res. 47 (2002) 291-300
31. Meijer A. Child psychiatric sequelae of maternal war stress. Acta Psychiatr. Scand. 72 (1985) 505-511
32. Myers K.J., Murthy S., Flanigan A., Witchell D.R., Butler M., Murray S., Siwkowski A., Goodfellow D., Madsen K., and Baker B. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. J. Pharmacol. Exp. Ther. 304 (2003) 411-424
33. Ng P.C. The fetal and neonatal hypothalamic-pituitary-adrenal axis. Arch. Dis. Child., Fetal Neonatal Ed. 82 (2000) F250-F254
34. Nicholson W.E., Davis D.R., Sherrell B.J., and Orth D.N. Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin. Chem. 30 (1984) 259-265
35. Nicosia A., Giardina L., Di Leo F., Medico M., Mazzola C., Genazzani A.A., and Drago F. Long-lasting behavioral changes induced by pre- or neonatal exposure to diazepam in rats. Eur. J. Pharmacol. 469 (2003) 103-109
36. O'Regan D., Welberg L.L., Holmes M.C., and Seckl J.R. Glucocorticoid programming of pituitary-adrenal function: mechanisms and physiological consequences. Semin. Neonatol. 6 (2001) 319-329
37. Phillips D.I., Barker D.J., Fall C.H., Seckl J.R., Whorwood C.B., Wood P.J., and Walker B.R. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome?. J. Clin. Endocrinol. Metab. 83 (1998) 757-760
38. Phillips D.I., Walker B.R., Reynolds R.M., Flanagan D.E., Wood P.J., Osmond C., Barker D.J., and Whorwood C.B. Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 35 (2000) 1301-1306
39. Pirollo K.F., Rait A., Sleer L.S., and Chang E.H. Antisense therapeutics: from theory to clinical practice. Pharmacol. Ther. 99 (2003) 55-77
40. Reynolds R.M., Walker B.R., Syddall H.E., Andrew R., Wood P.J., Whorwood C.B., and Phillips D.I. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 86 (2001) 245-250
41. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N. Engl. J. Med. 353 (2005) 1711-1723
42. Salehi M., Ferenczi A., and Zumoff B. Obesity and cortisol status. Horm. Metab. Res. 37 (2005) 193-197
43. Sanabria E.R., Pereira M.F., Dolnikoff M.S., Andrade I.S., Ferreira A.T., Cavalheiro E.A., and Fernandes M.J. Deficit in hippocampal long-term potentiation in monosodium glutamate-treated rats. Brain Res. Bull. 59 (2002) 47-51
44. Sapolsky R.M., and Meaney M.J. Maturation of adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res. Rev. 394 (1986) 64-67
45. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. 151 (2004) U49-U62
46. Singhal A., and Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis?. Lancet 363 (2004) 1642-1645
47. Spampinato S., Canossa M., Carboni L., Campana G., Leanza G., and Ferri S. Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to β-endorphin mRNA. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8072-8076
48. Spampinato S., and Goldstein A. Immunoreactive dynorphyn in rat tissues and plasma. Neuropeptides 3 (1983) 193-212
49. Williams M.T., Inman-Wood S.L., Morford L.L., McCrea A.E., Ruttle A.M., Moran M.S., Rock S.L., and Vorhees C.V. Preweaning treatment with methamphetamine induces increases in both corticosterone and ACTH in rats. Neurotoxicol. Teratol. 22 (2000) 751-759
50. Williams M.T., Moran M.S., and Vorhees C.V. Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology 168 (2003) 329-338
51. Yilmazer-Hanke D.M., Hantsch M., Hanke J., Schulz C., Faber-Zuschratter H., and Schwegler H. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of Wistar rats. Neuroscience 124 (2004) 283-297
52. Zhang M.M., Yu K., Xiao C., and Ruan D.Y. The influence of developmental periods of sodium valproate exposure on synaptic plasticity in the CA1 region of rat hippocampus. Neurosci. Lett. 351 (2003) 165-168